Meliora Therapeutics
Meliora Therapeutics: A biotech startup leveraging machine learning to decode oncology medications.
Founded
2021Meliora Therapeutics: A biotech startup leveraging machine learning to decode oncology medications.
Meliora Therapeutics, founded with a mission to revolutionize oncology drug development, leverages a machine learning-driven platform to identify the true mechanisms of action of cancer medications. The company integrates modern molecular fingerprinting, machine learning, and advanced biology to create precision oncology drugs, aiming to overcome the high failure rate in clinical testing of cancer therapies. Their market focus is on developing more effective and targeted treatments for cancer patients.
Notable figures affiliated with Meliora Therapeutics include experts in machine learning and oncology drug development, though specific names are not provided. The company has garnered attention for its innovative approach and has likely attracted investment from venture capital firms interested in biotech and AI. Key achievements include the development of their proprietary platform, which holds the potential to significantly impact the success rates of oncology drugs in clinical trials, thereby improving patient outcomes and advancing the field of precision medicine.
Companies similar to Meliora Therapeutics include Melior Discovery, Eigen Therapeutics, First Ascent Biomedical and Melior Pharmaceuticals.
Meliora Therapeutics was founded in 2021.
Meliora Therapeutics' headquarters is located in San Francisco, CA, US.
Meliora Therapeutics' most recent funding round was for $11M (USD) in September 2022.
As of Sep 29, 2022, Meliora Therapeutics has disclosed funding of $11M (USD). Undisclosed round amounts are excluded.
Meliora Therapeutics has 7 employees as of Feb 4, 2024.
Melior Pharmaceuticals
